Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 22.29
+1.79 (8.73%)
At close: Mar 27, 2026
Bio-Thera Solutions Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 289.8 | 163.99 | 165.94 | 847.47 |
Trading Asset Securities | - | 90.22 | 331.03 | 629.89 | 602.83 |
Cash & Short-Term Investments | 267.15 | 380.02 | 495.01 | 795.83 | 1,450 |
Cash Growth | -29.70% | -23.23% | -37.80% | -45.13% | 17.03% |
Accounts Receivable | - | 108.26 | 148.72 | 89.75 | 103.32 |
Other Receivables | - | 4.23 | 2.09 | 1.96 | 3.67 |
Receivables | - | 112.5 | 150.8 | 91.72 | 106.99 |
Inventory | - | 253.1 | 231.23 | 161.9 | 90.1 |
Other Current Assets | - | 142.34 | 133.36 | 112.81 | 123.08 |
Total Current Assets | - | 887.95 | 1,010 | 1,162 | 1,770 |
Property, Plant & Equipment | - | 1,066 | 1,014 | 693.91 | 579.43 |
Long-Term Investments | - | 15.7 | 10 | - | 21.1 |
Other Intangible Assets | - | 224.1 | 230.38 | 234.18 | 239.47 |
Long-Term Deferred Charges | - | 3.5 | 2.01 | - | - |
Other Long-Term Assets | - | 8.09 | 19.86 | 89.39 | 7.31 |
Total Assets | - | 2,206 | 2,287 | 2,180 | 2,618 |
Accounts Payable | - | 199.49 | 171.45 | 83.77 | 12.73 |
Accrued Expenses | - | 88.53 | 69.51 | 67.41 | 90.91 |
Short-Term Debt | - | 88.75 | 105.4 | 0.01 | 30.05 |
Current Portion of Long-Term Debt | - | 169.4 | 50.21 | - | - |
Current Portion of Leases | - | - | 3.18 | 3.49 | 2.38 |
Current Income Taxes Payable | - | - | - | 0 | - |
Current Unearned Revenue | - | 545.33 | 318.5 | 374.08 | 381.61 |
Other Current Liabilities | - | 4.23 | 7.17 | 9.74 | 8.36 |
Total Current Liabilities | - | 1,096 | 725.42 | 538.5 | 526.04 |
Long-Term Debt | - | 370.43 | 323.84 | 3 | - |
Long-Term Leases | - | - | - | 3.01 | - |
Long-Term Unearned Revenue | - | 31.29 | 25.13 | 27.97 | 4.23 |
Total Liabilities | - | 1,497 | 1,074 | 572.48 | 530.27 |
Common Stock | - | 414.08 | 414.08 | 414.08 | 414.08 |
Additional Paid-In Capital | - | 3,054 | 3,054 | 3,054 | 3,054 |
Retained Earnings | - | -2,766 | -2,256 | -1,861 | -1,381 |
Comprehensive Income & Other | - | 5.68 | 0 | 0.01 | -0.13 |
Shareholders' Equity | 484.16 | 708.09 | 1,213 | 1,607 | 2,088 |
Total Liabilities & Equity | - | 2,206 | 2,287 | 2,180 | 2,618 |
Total Debt | 649.69 | 628.58 | 482.62 | 9.51 | 32.43 |
Net Cash (Debt) | -382.54 | -248.56 | 12.39 | 786.33 | 1,418 |
Net Cash Growth | - | - | -98.42% | -44.54% | 14.41% |
Net Cash Per Share | -0.92 | -0.60 | 0.03 | 1.90 | 3.46 |
Filing Date Shares Outstanding | 414.08 | 414.08 | 414.08 | 414.08 | 414.08 |
Total Common Shares Outstanding | 414.08 | 414.08 | 414.08 | 414.08 | 414.08 |
Working Capital | - | -207.78 | 284.98 | 623.76 | 1,244 |
Book Value Per Share | 1.17 | 1.71 | 2.93 | 3.88 | 5.04 |
Tangible Book Value | 264.58 | 483.99 | 982.34 | 1,373 | 1,848 |
Tangible Book Value Per Share | 0.64 | 1.17 | 2.37 | 3.32 | 4.46 |
Buildings | - | 291.95 | 291.16 | 281.63 | 220.84 |
Machinery | - | 663.05 | 608.15 | 569.52 | 507.47 |
Construction In Progress | - | 580.96 | 505.21 | 155.83 | 95.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.